Summary:
Longitudinal Evaluation of [18F]MNI-798 as a PET Radioligand for Imaging Tau in the Brain of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers
Qualified Participants Must:
Be between 50 and 80 years of age
Have a study partner
Be healthy
Have memory loss
Qualified Participants May Receive:
Compensation for their time and travel